It was further shown that bisphosphonates inhibit the vascular endothelial growth factor (VEGF)-mediated angiogenesis of breast cancer cells via suppression of the IGF-1/AKT/HIF-1α/VEGF axis [97]. This evidence concerns the gene IGF1 and breast cancer.